Essential technologies help keep this website secure and working. With your permission, we use optional analytics to understand what works and improve the website. You can browse and enquire without accepting optional cookies, and change your choices at any time. See our Cookie & Similar Technologies Notice.
Clinical Safety Officer wording revision · Preview only
Digital clinical safety governance
Outsourced Clinical Safety Officer Services
An outsourced Clinical Safety Officer (CSO) gives digital health, healthcare SaaS and NHS teams clinical safety leadership, evidence and ongoing help. Support is delivered by a registered clinician under an agreed mandate, in line with applicable NHS clinical safety standards.
Named clinical safety leadership, linked to governance and delivery.
You need a named Clinical Safety Officer for a product or deployment
02
Your current CSO needs extra help with evidence, reviews or change
03
Your HealthTech team is preparing clinical safety evidence for NHS market entry
04
Your NHS or care organisation needs DCB0160 deployment and local workflow assurance
05
Releases, AI features or integrations are changing the clinical risk profile
06
You need a scoped DCB0129 or DCB0160 review or evidence development project
The service
Practical clinical safety risk management
A CSO role needs active clinical input, not just a final signature. IG-Smart provides a named appointment under agreed clinical risk management arrangements, or specialist support beside an existing CSO. Defined-scope assessment, clinical safety audit and clinical safety case development are available through Clinical Safety Consultancy. The manufacturer or deploying organisation stays accountable for its systems and use. Appointment and clinical review duties are separate from organisational risk acceptance and deployment authority.
Appointment and decision rights
An agreed clinical mandate. Clear organisational decision rights.
Formal CSO appointment
IG-Smart can provide the named practitioner; your organisation confirms the appointment, mandate and governance arrangements.
Clinical review and approval
The appointed CSO performs the clinical review and approvals required by the applicable standard and documented appointment. In support-only engagements, your existing CSO retains those duties.
Residual-risk acceptance
Authorised individuals in your organisation accept residual clinical risk and release decisions.
Organisational accountability
Accountability for clinical safety stays with the manufacturer or deploying organisation.
Two related services
Which service fits?
Choose Clinical Safety Officer Services for a named appointment or ongoing support for an existing CSO. Choose Clinical Safety Consultancy for defined-scope assessment, evidence development or implementation support. Appointment provision can form part of an engagement where expressly agreed.
Appointment or ongoing support · You are hereClinical Safety Officer ServicesA named CSO within an agreed mandate, or additional specialist capacity alongside your existing CSO. Client accountability and decision rights remain explicit.
DCB0129
Manufacturer responsibilities
Applies to organisations manufacturing health IT systems: clinical risk management across development, release, maintenance and change of the product.
DCB0160
Deployment and use responsibilities
Applies to health and care organisations deploying and using those systems: local configuration, workflows, training and operational change.
Supplier evidence does not automatically satisfy a deploying organisation’s obligations. Applicability depends on the product, intended use and deployment context; the current published standards remain the operative requirements while NHS England’s review continues.
Already have an appointed CSO?
This service supports their clinical-risk-management processes, safety evidence, change reviews and governance reporting. Your appointed CSO retains clinical review and approval responsibilities.
Need a formally appointed CSO?
IG-Smart can provide a named senior clinical safety professional for an agreed CSO appointment. Suitability, current eligibility, availability, scope and responsibilities are checked before appointment. Your organisation retains accountability and authorised risk-acceptance and deployment decisions.
Why IG-Smart
Clinical safety connected to the rest of your assurance
Clinical safety rarely fails in isolation. Our wider governance, risk and assurance work means clinical risk evidence stays consistent with privacy, security, supplier and board reporting. These are the connections we draw on; each engagement’s scope is agreed separately, and not every capability below is included in CSO support.
Governance and accountability
Clear decision rights, escalation routes and RACI, so clinical safety sits inside organisational governance rather than beside it.
Service lead Michael Abtar’s experience includes serving as Clinical Safety Officer for Royal Brompton & Harefield NHS Foundation Trust. Read the RBHT case study
An appropriately qualified senior professional fills the agreed appointment and clinical risk management role.
Clinical safety governance
Clear duties, decisions, escalation and reporting across clinical, product, technical and executive teams.
DCB0129/DCB0160 activities
Clinical risk management and evidence work matched to manufacture or deployment and use; the two duties stay separate.
Safety evidence development
Identifying gaps, reviewing hazards and developing or assessing the agreed safety case, hazard log and clinical risk management records.
NHS assurance coordination
Clinical safety evidence linked to relevant DTAC and wider governance workstreams where commissioned.
Release and continuing assurance
Advice, evidence updates and review of changes or incidents within the agreed scope and cadence.
How the engagement runs
From an agreed mandate to ongoing assurance
The engagement model determines who carries out clinical review, what delivery includes and how ongoing support works.
1
Assess
Review intended use, duties, existing evidence and whether you need a named CSO, support or consultancy.
2
Build
Agree the named practitioner where needed, check suitability and current eligibility, record decision rights and build the agreed evidence.
3
Manage
Provide clinical safety leadership or support under the agreed mandate, aligning product, clinical and programme teams.
4
Assure
Review hazards, controls and evidence against the applicable standard and written appointment; escalate unresolved issues to authorised decision-makers.
5
Improve
Use release reviews, incident learning and periodic review to update evidence and working methods where commissioned.
→ Clinical review and approvals follow the applicable standard and written appointment. Unresolved issues follow the agreed escalation routes; organisational decisions remain with authorised decision-makers. Every engagement follows IG-Smart’s structured delivery approach: Assess → Build → Manage → Assure → Improve. Explore how we work
What each stage produces
01
Assess
Agreed scope, appointment model and evidence gaps.
02
Build
Appointment and responsibility records; agreed safety documents.
03
Manage
Maintained evidence, action tracking and change-review records.
04
Assure
Clinical review, assurance findings and decision-support evidence.
05
Improve
Updated evidence and prioritised improvement actions.
Engagement options
Appointed CSO services or support for your existing CSO
Appointed Clinical Safety Officer Services
A named senior professional for an agreed CSO role
Suitability, current eligibility and availability checked before appointment
Mandate, clinical responsibilities, approval authority and escalation documented
Clinical Safety Officer Support
Governance, risk management, evidence-development and assurance capacity
Ongoing support or a focused requirement
Your existing CSO continues the agreed clinical review role
For scoped assessment, clinical safety audits, clinical safety case development or DCB0129 support, see Clinical Safety Consultancy through the service selector above. Consultancy is scoped and quoted separately. It does not automatically create a CSO appointment.
What you receive
What evidence will be produced?
Outputs are agreed for the product, deployment and lifecycle stage. The example below is not a live assessment, completed safety case, clinical approval or proof of compliance.
Illustrative data — not client data
Illustrative Appointment and accountability record
Activity
Appointed-CSO model
Existing-CSO support
Client responsibility
CSO mandate
Named IG-Smart practitioner; terms agreed
Existing appointed CSO
Confirm appointment and governance arrangements
Clinical review
Applicable standard and documented appointment
Existing CSO; IG-Smart supports evidence
Provide information and authorised escalation routes
Risk acceptance / deployment
Clinical advice and review within mandate
Evidence and decision support
Authorised organisational decision-makers
Appointment and accountability record
Responsibility map
Shows the difference between an IG-Smart appointment and support for an existing CSO, including the clinical duties and organisational decision paths to record.
What it helps you see
Mandate
Clinical review
Decision authority
Likely format
Role and decision-rights record
Illustrative structure — not a client document. Exact outputs and formats depend on the agreed scope.
Scope boundaries
Clinical leadership with clear accountability
Agreed responsibilities
Named CSO provision where expressly agreed
Clinical safety governance and risk assessment
Clinical Safety Case Report, Hazard Log and Clinical Risk Management File where scoped
Change review and ongoing advice where commissioned
Responsibilities and limits
Your organisational, operational and regulatory accountability
Authorised residual-risk acceptance, release and deployment decisions
No guarantee of NHS procurement acceptance, regulatory approval or a harm-free system
Appointment eligibility, capacity, scope and fees must be confirmed; no automatic appointment from an enquiry
Scope, deliverables and assumptions are agreed in writing before work begins.
Relevant evidence
Related NHS and HealthTech evidence
Selected published engagements show relevant governance, assurance and NHS and HealthTech capability. They are not presented as CSO engagements unless the underlying approved case evidence expressly states that.
Named client · Healthcare / NHS
Royal Brompton & Harefield NHS Foundation Trust
Three-year managed service: Information Governance, data quality, Payment by Results, trust-wide information security and clinical systems safety, reporting to the board-level SIRO
Three-year managed IG, data quality, security & clinical systems safety service · reporting to the board-level SIRO
The approved Royal Brompton & Harefield engagement documents a managed NHS governance and clinical systems safety service. Michael Abtar's practitioner experience is attributed separately; the case is not used to infer another practitioner's registration or current availability.
Embedded governance and clinical-safety support since start-up
NHS AI Toolkit, DSPT, DTAC and clinical-safety governance from start-up
The approved Clini-Hub case describes clinical safety case reports and DCB0129/DCB0160 support alongside NHS and AI governance. The client's compliance statement is client-reported, not an independent certification.
Specialist expertise, coordinated around your requirement
Subject-matter expertise is paired with a clear client and programme contact from initial scoping through delivery.
Clinical Safety Officer and health informatics specialist
Himanshu Desai
MSc, MBA, MRPharmS
Specialist expertise in health informatics, prescribing and medication-management systems. Has attended NHS England’s Digital Clinical Safety – Practitioner course; his certificate of attendance is available on request.
Service lead — clinical safety governance and multidisciplinary assurance
Michael Abtar
LLB (Hons), PG.Dip.Law, Cert. DPO
Leads the service, drawing on his experience as Clinical Safety Officer at Royal Brompton & Harefield and coordinating clinical safety with information governance, privacy, cyber assurance and organisational accountability.
Himanshu Desai attended NHS England’s Digital Clinical Safety – Practitioner course. His certificate of attendance is available on request.
Clinical safety training
Digital Clinical Safety – Practitioner
Provider
NHS England
Evidence
Certificate of attendance signed by the Clinical Director for Patient Safety; available upon request
Course attendance is training, not a separate professional certification. Professional membership and postnominals do not establish current statutory registration or appointment eligibility; training does not imply NHS endorsement of IG-Smart.
Do DCB0129 and DCB0160 require a Clinical Safety Officer?
Yes. NHS guidance states that both standards require the organisation to nominate a Clinical Safety Officer. The CSO should be a senior clinician with current professional registration and sufficient training in clinical safety and clinical risk management.
Does IG-Smart provide an appointed Clinical Safety Officer?
Yes. IG-Smart provides appropriately qualified, named senior clinical safety professionals who can take on an agreed CSO role within the client's clinical risk management arrangements. We also support organisations with an existing CSO. The named practitioner's suitability, current eligibility, availability, duties and appointment terms are checked and agreed before engagement. Appointment does not transfer the client's organisational accountability or all risk-acceptance, release and deployment decisions to IG-Smart.
Is the CSO responsible only for signing the safety case?
No. The role should provide active clinical safety leadership: finding hazards, reviewing risks and controls, checking evidence quality, reviewing changes, learning from incidents and reporting on governance. A signature without enough involvement does not create credible assurance.
How do DCB0129 and DCB0160 differ?
DCB0129 applies to manufacturers that develop and maintain health IT systems. DCB0160 applies to health organisations that deploy and use them. Supplier evidence does not automatically meet a deployer's duties, so both sides often need to align evidence, transferred risks, local workflows, configuration, training and operational change.
Are the standards changing?
NHS England is reviewing DCB0129 and DCB0160. Its published standards pages currently list the 2018 releases. We check the applicable requirements when scoping an engagement.
Can CSO support help with DTAC?
Yes. Clinical safety is one of the core DTAC areas. IG-Smart can help make the hazard log, clinical safety case and supporting governance clear, current and ready for review by buyers. This does not guarantee procurement acceptance.
What does the £3,000 + VAT monthly starting investment cover?
The retained service is for ongoing governance, reviews, release assurance, board reporting and incident support alongside your existing CSO. This starting investment excludes an appointed CSO. Appointed-CSO engagements are individually scoped and quoted; no appointment price is published. Scope, outputs, duties, capacity and fees are confirmed in writing before work starts. The starting investment is not a fixed number of hours, systems or releases. Onboarding, initial safety-case development and substantial remediation are quoted separately where needed.
Who leads the work, and who approves clinical safety decisions?
Michael Abtar leads clinical safety governance and cross-team assurance; Himanshu Desai brings health informatics and clinical safety expertise. Practitioner allocation and capacity are agreed during scoping. The appointed CSO carries out the clinical review and approvals required by the applicable standard and written appointment. In support-only engagements, your current CSO keeps those duties. Authorised organisational decision-makers retain risk-acceptance, release and deployment authority. Experience, membership and training do not establish current professional registration or appointment eligibility.
What happens when our product or deployment changes?
Releases, AI-enabled features, configuration, integrations, workflows or new uses may change the clinical risk profile. Within the agreed scope, we assess change impacts, review affected hazards and controls, and update the hazard log, safety case and decision records. Unresolved issues follow the agreed clinical review and governance routes to authorised decision-makers.
How should an organisation decide between Clinical Safety Officer Services and Clinical Safety Consultancy?
Choose Clinical Safety Officer Services for a named CSO appointment or ongoing support for your current CSO. Choose Clinical Safety Consultancy for a scoped assessment, evidence development, clinical safety audit, implementation support or review without an automatic CSO appointment. Appointment provision must be expressly agreed, scoped and documented.
What evidence or documentation might the team produce during an engagement?
Depending on the product, deployment context and agreed scope, outputs may include appointment and accountability records, responsibility maps, hazard logs, clinical safety case reports, clinical risk management files, evidence gap assessments, change-review records, assurance findings and decision-support evidence. Exact outputs and formats are agreed in writing before work begins.
Investment
Starting investment: £3,000 + VAT per month
This published starting investment applies only to retained support alongside your existing CSO and excludes an appointed CSO. Appointed-CSO engagements are individually scoped and quoted; no appointment price is published. Capacity, duties and fees are confirmed in writing. Onboarding, initial safety-case development and substantial remediation are quoted separately where needed. Defined-scope consultancy is scoped separately.
Choose the right commercial model
Appointed CSO — named role, mandate and fee agreed individually
Existing-CSO support — retained support or focused additional capacity
Defined-scope consultancy — assessment, evidence or implementation requirement
Peer review — conflicts and independence assessed for the proposed reviewer and scope
Supplier-portal registration does not imply accreditation, endorsement, preferred-supplier status or approval by every organisation using the platform.